Thus, we investigated the tumor suppressor role of knocking down circUBE2Q2 in vivo and whether combination of circUBE2Q2 knocking down and stattic (a common STAT3 inhibitor) could result in additive or synergistic effects on the growth of GC in vivo. The gene discussed is STAT3; the disease is gastric cancer.